Anti-interleukin-2 receptor monoclonal antibody therapy induces anti-idiotypic antibodies in mice that block both in vitro and in vivo activity
- 1 April 1988
- journal article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 1 (2) , 119-130
- https://doi.org/10.1016/0896-8411(88)90020-0
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells.The Journal of Experimental Medicine, 1987
- Autoimmune diabetes in NOD mouse is L3T4 T-lymphocyte dependentDiabetes, 1987
- Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) miceDiabetes, 1986
- Preventive effects of Cyclosporin on diabetes in NOD miceDiabetologia, 1986
- Characterization of a monoclonal rat anti-mouse interleukin 2 (IL-2) receptor antibody and its use in the biochemical characterization of the murine IL-2 receptorClinical Immunology and Immunopathology, 1985
- Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice.The Journal of Experimental Medicine, 1985
- The inhibitory effect of neonatal thymectomy on the incidence of insulitis in non-obese diabetes (NOD) mice Biomedical Research, 1985
- Immunological aspect of non-obese diabetic mice: immune islet cell-killing mechanism and cell-mediated immunityDiabetologia, 1984
- The Interleukin-2 T-Cell System: A New Cell Growth ModelScience, 1984
- Breeding of a Non-Obese, Diabetic Strain of MiceExperimental Animals, 1980